￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Analysis of Opicapone’s official launch time and clinical promotion status

2026-02-01 22:25:32

Check Details
Fenelidone (Keshenda) usage and dosage and individual adjustment methods for different patients

2026-02-01 22:25:32

Check Details
Differences and price comparison between domestic and imported versions of Rasagiline

2026-02-01 22:25:32

Check Details
What are the common side effects of Platinib (Pujihua) and how to deal with them scientifically?

2026-02-01 22:25:32

Check Details
Common side effects of capmatinib (Touradida) and practical methods to alleviate them

2026-02-01 22:25:32

Check Details
Suggested reference for usage, dosage and optimal taking time of Sotorasibu (AMG 510)

2026-02-01 22:25:32

Check Details
The latest news on whether adagrasib (Krazati) has been included in medical insurance and the reimbursement ratio of medical insurance in various places

2026-02-01 22:25:32

Check Details
Larotrectinib 2025 medical insurance price and reimbursement policy explanation

2026-02-01 22:25:32

Check Details
The latest price and medical insurance reimbursement status of Selinexor in 2025

2026-02-01 22:25:32

Check Details
Comprehensive analysis of the efficacy, functions and indications of Vigabatrin (Okeda)

2026-02-01 22:25:32

Check Details
The latest price and market reference of Moboxetinib (Anvili) in 2025

2026-02-01 22:25:32

Check Details
Analysis of the reasons why some patients are not recommended to take Tepotinib (Tuodekang)

2026-02-01 22:25:32

Check Details
Category
相关知识